Pfizer Taiwan and Taiwan CDC Launch a Public-Private Partnership Against the Global AMR Threat
Taiwan’s fight against antimicrobial resistance is entering a new phase as Taiwan CDC and Pfizer formalize a public-private partnership to strengthen surveillance, research, and public education. The new MOU underscores the urgency of AMR and aligns with Taiwan’s expanding One Health strategy.